MedPath

Stelara

Brand Name: Stelara

Generic Name: Ustekinumab

Active
Registration Number

BR-1415

Dosage Form

Solution For Injection (SC)

Issuance Date

August 31, 2022

Expiry Date

August 31, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength45 mg/0.5 mL
Packaging0.5 mL in 2 mL Type I glass vial with butyl rubber stopper and aluminum seal with light-green flip-off button (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Interleukin Inhibitors
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

UstekinumabActive
Monograph: Ustekinumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform